Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
11,549,491
-
Total 13F shares
-
10,000
-
Share change
-
0
-
Total reported value
-
$3,555
-
Price per share
-
$0.36
-
Number of holders
-
1
Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) as of Q4 2021
As of 31 Dec 2021,
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
10,000 shares.
The largest 1 holders included
SILVERLAKE WEALTH MANAGEMENT LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.